Novo Nordisk’s drug stumble leaves it suddenly much slimmer

Market will never be winner takes all given that different patients will have different requirements

Topics

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point Friday after reporting trial results that missed expectations.
CNBC - 59m
The 'laughingstock of the NFL' has suddenly started winning

After nearly 30 years of poor play on the field and controversy off of it, it's finally fun to root for the Washington NFL franchise again.
NBC News - 10h
Novo Nordisk shares tumble as weight-loss drug trial data disappoints

Obesity drug CagriSema misses goal of 25% body weight reduction
Financial Times - 8h
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition

A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, a new Doximity report finds.
CNBC - 2d
Chelsea the big winners as Europe's giants stumble

Chelsea nabbed all three points on a remarkable weekend that saw Man City, Barca and Bayern all lose.
ESPN - 4d
Novo Nordisk to invest $1.2 billion in new plant in Denmark

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the production of rare disease drugs, it said on Monday. "Designed to be ...
Yahoo Sports - 4d
Mephisto, the Maker of Grandpa Shoes, Is Suddenly Cool

With a zesty collaboration arriving this week, the French shoemaker Mephisto is suddenly something it never dreamed of being before: cool.
The New York Times - Dec. 11
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
CNBC - Dec. 4
Mark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’

“I’m not trying to land on Mars,” Cost Plus Drugs founder Mark Cuban joked at WIRED’s The Big Interview event.
Wired - Dec. 3

Novo Nordisk’s drug stumble leaves it suddenly much slimmer

Topics

Related

Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

The 'laughingstock of the NFL' has suddenly started winning

Novo Nordisk shares tumble as weight-loss drug trial data disappoints

Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition

Chelsea the big winners as Europe's giants stumble

Novo Nordisk to invest $1.2 billion in new plant in Denmark

Mephisto, the Maker of Grandpa Shoes, Is Suddenly Cool

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Mark Cuban’s War on Drug Prices: ‘How Much Fucking Money Do I Need?’

More from Financial Times

Trump wants 5% Nato defence spending target, Europe told

Trump tells EU to buy US oil and gas or face tariffs

There is a way out of the doom loop for Labour

Car ploughs into Christmas market in Germany

Mandelson slammed as ‘moron’ by Trump adviser after being named US ambassador